Acta Diabetologica

, Volume 50, Issue 1, pp 81–87

Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting

  • C. B. Giorda
  • M. F. Mulas
  • V. Manicardi
  • C. Suraci
  • P. Guida
  • L. Marafetti
  • E. Nada
  • S. Gentile
Original Article


The time to achieve good metabolic control after diagnosis is essential for type 2 diabetes patients because it can influence long-term prognosis. This study aimed to elucidate the predictive role of several clinical and organization factors in normalizing metabolism within 6 months. A multi-centered, retrospective, observational study on 960 patients, with diabetes duration of 12 months or less, consecutively seen in 123 Italian clinics, was undertaken. Information about clinic’s organization, along with data abstracted from medical records at enrollment (first visit) and after 6 months (follow-up visit), was collected. At 6 months, HbA1c dropped by −3.1 ± 2.2 points in those who achieved HbA1c <7 % (responders), whereas in non-responders (HbA1c ≥7 %), the mean reduction was −1.8 ± 1.9. The intervention markedly reduced lipids, blood pressure, BMI, and waist circumference, especially in responders. The presence of a diabetes team correlated with a likelihood of HbA1c normalization (OR 1.94, 1.17–3.22). By contrast, indicators of advanced disease such as previous retinopathy (0.53, 0.29–0.98), use of secretagogues (0.40, 0.25–0.64), high levels of HbA1c at first visit and related insulin use emerged as adverse factors. Early detection of diabetes, along with human resources and organization, was found to play a crucial role in rapidly attaining good metabolic control.


HbA1c normalization Type 2 diabetes treatment  Organizational factors Clinical factors 


  1. 1.
    The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653CrossRefGoogle Scholar
  2. 2.
    Holman RR, Sanjoy KP, Bethel MA, Matthews DR, Neil HAW (2008) 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMedCrossRefGoogle Scholar
  3. 3.
    Gæde P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591PubMedCrossRefGoogle Scholar
  4. 4.
    Ceriello A, Ihnat MA, Thorpe JE (2009) Clinical review 2: the “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab (United States) 94(2):410–415CrossRefGoogle Scholar
  5. 5.
    De Micheli A (2008) Italian standards for diabetes mellitus 2007: executive summary Diabete Italia, AMD Associazione Medici Diabetologi, SID Societa` Italiana di Diabetologia. Acta Diabetol 45:107–127CrossRefGoogle Scholar
  6. 6.
    American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diabetes Care 33 (Supplement, January)Google Scholar
  7. 7.
    White NH, Sun W, Cleary PA et al (2008) Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol (United States) 126(12):1707–1715CrossRefGoogle Scholar
  8. 8.
    Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM (2006) The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55(12):3556–3565. ISSN: 0012-1797Google Scholar
  9. 9.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y (2009) IMPROVE Study Group Expert Panel. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. Int J Clin Pract 63(3):522–531. Epub 2009 Jan 27Google Scholar
  10. 10.
    Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, Stehouwer CD, Bouter LM, Heine RJ (2003) Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the HOOM screening study. Diabetes Care 26(9):2604–2608PubMedCrossRefGoogle Scholar
  11. 11.
    Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819PubMedCrossRefGoogle Scholar
  12. 12.
    Giorda CB, Guida P, Avogaro A, Cortese C, Mureddu GF, Corsini A, Comaschi MA, Manzato E, Volpe M, Zito GB, Medea G, Ventriglia G, Titta G, Riccardi G, EFFECTUS Steering Committee (2009) Association of physicians’ accuracy in recording with quality of care in cardiovascular medicine. Eur J Cardiovasc Prev Rehabil 16(6):722–728Google Scholar
  13. 13.
    Engelgau MM, Narayan KM, Herman WH (2000) Screening for type 2 diabetes. Diabetes Care 23:1563–1580PubMedCrossRefGoogle Scholar
  14. 14.
    Gnavi R, Picariello R, la Karaghiosoff L, Costa G, Giorda C (2009) Determinants of quality in diabetes care process: the population-based Torino Study. Diabetes Care 32(11):1986–1992 [Epub 2009 Aug 12]Google Scholar
  15. 15.
    Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C (2005) Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 28(3):600–606PubMedCrossRefGoogle Scholar
  16. 16.
    Mc Allister FA, Majumdar SR, Eurich DT, Johnson JA (2007) The effect of specialist care within the first year on subsequent outcomes in 24232 adults with new-onset diabetes mellitus: population-based cohort study. Qual Saf Health Care 16:6–11CrossRefGoogle Scholar
  17. 17.
    Levetan CS, Salas J, Wilets IF, Zumoff B (1995) Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 99:22–28PubMedCrossRefGoogle Scholar
  18. 18.
    Koproski J, Pretto Z, Poretsky L (1997) Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 20:1553–1555PubMedCrossRefGoogle Scholar
  19. 19.
    Phillips LS, Branch WT Jr, Cook CB, Doyle JP (2001) Clinical inertia. Ann Intern Med 135:825–834PubMedGoogle Scholar
  20. 20.
    Larme AC, Pugh JA (2001) Evidence-based guidelines meet the real world the case of diabetes care. Diabetes Care 24(10):1728–1733PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • C. B. Giorda
    • 1
  • M. F. Mulas
    • 2
  • V. Manicardi
    • 3
  • C. Suraci
    • 4
  • P. Guida
    • 5
  • L. Marafetti
    • 1
  • E. Nada
    • 6
  • S. Gentile
    • 7
  1. 1.Metabolism and Diabetes UnitASLTurin 5Italy
  2. 2.Metabolism and Diabetes UnitOristanoItaly
  3. 3.Montecchio HospitalMontecchio EmiliaItaly
  4. 4.Metabolism and Diabetes UnitPertini HospitalRomeItaly
  5. 5.Cardiology Unit, Emergency and Organ Transplantation DepartmentUniversity of BariBariItaly
  6. 6.Chaira Medica AssociationChieriItaly
  7. 7.University of NaplesNaplesItaly

Personalised recommendations